A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 64, Issue 1, Pages -
Publisher
American Society for Microbiology
Online
2019-10-23
DOI
10.1128/aac.01655-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population pharmacokinetics of unbound ceftolozane and tazobactam in critically ill patients without renal dysfunction
- (2019) Fekade B Sime et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hospital Variation in Renal Replacement Therapy for Sepsis in the United States
- (2018) Thomas S. Valley et al. CRITICAL CARE MEDICINE
- Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience
- (2018) Matteo Bassetti et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- MIC-based dose adjustment: facts and fables
- (2017) Johan W Mouton et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration
- (2016) Joseph L. Kuti et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftolozane/Tazobactam Pharmacokinetics in a Critically Ill Adult Receiving Continuous Renal Replacement Therapy
- (2016) Derek N. Bremmer et al. PHARMACOTHERAPY
- Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
- (2015) Wesley D. Oliver et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antibiotic Dosing in Critically Ill Patients Receiving CRRT: Underdosing is Overprevalent
- (2015) Susan J. Lewis et al. SEMINARS IN DIALYSIS
- Impact of MIC Range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the CeftolozaneIn VivoPharmacokinetic/Pharmacodynamic Target
- (2014) A. J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
- (2014) G. Wong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
- (2014) Jason A Roberts et al. LANCET INFECTIOUS DISEASES
- In VivoActivities of Ceftolozane, a New Cephalosporin, with and without Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, Including Strains with Extended-Spectrum β-Lactamases, in the Thighs of Neutropenic Mice
- (2012) W. A. Craig et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Improving antibiotic dosing in special situations in the ICU
- (2012) Janattul-Ain Jamal et al. Current Opinion in Critical Care
- Dosing of Antibiotics in Critically Ill Patients Undergoing Renal Replacement Therapy
- (2011) Jan T. Kielstein et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Antibiotic dosing in critically ill patients with acute kidney injury
- (2011) Rachel F. Eyler et al. Nature Reviews Nephrology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now